Huma Qamar - Jan 2, 2025 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Chief Medical Officer
Signature
/s/ Huma Qamar by Shankar Musunuri, her attorney-in-fact
Stock symbol
OCGN
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/6/2025, 05:01 PM
Previous filing
Apr 17, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +1.15M $0.00 1.15M Jan 2, 2025 Common Stock 1.15M $0.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates.